Journal profile · Pharmacology & Pharmacy
THERAPIE
ISSN 0040-5957 · eISSN 1958-5578 · Elsevier Masson SAS · FRANCE · Bimonthly · Founded 1946
THERAPIE: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2; hybrid open access; APC about USD 3,450; median 93 days to acceptance (98 articles, last 24 months); community-reported acceptance: easy; 93 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
THERAPIE is published by Elsevier Masson SAS and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacovigilance and Adverse Drug Reactions, Health Systems, Economic Evaluations, Quality of Life and Pharmaceutical Practices and Patient Outcomes, together about 25.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Official publication of the Société Française de Pharmacologie et de Thérapeutique (SFPT) – Organe officiel de la Société Française de Pharmacologie et de Thérapeutique (SFPT)Therapies is a peer-reviewed journal devoted to Clinical Pharmacology, Therapeutics, Pharmacokinetics, Pharmacovigilance, Addictovigilance, Social Pharmacology, Pharmacoepidemiology, Pharmacoeconomics and Evidence-Based-Medicine. Thérapie publishes in French or in English original articles, general reviews, letters to the editor reporting original findings, correspondence relating to articles or letters published in the Journal, short articles, editorials on up-to-date topics, Pharmacovigilance or Addictovigilance reports that follow the French "guidelines" concerning good practice in pharmacovigilance publications. The journal also publishes thematic issues on topical subject. The journal is indexed in the main international data bases and notably in: Biosis Previews/Biological Abstracts, Embase/Excerpta Medica, Medline/Index Medicus, Science Citation Index.Thérapies est un journal bimensuel consacré à des sujets de pharmacologie clinique, de thérapeutique, de pharmacocinétique, de pharmacovigilance, d'addictovigilance, de pharmacologie sociale, de pharmacoépidémiologie, de pharmacoéconomie ou de médecine factuelle. La revue publie en langue française ou anglaise des mémoires originaux, des revues générales, des lettres à la rédaction exposant des faits originaux, des correspondances à propos d'articles ou de lettres publiés dans la revue, des observations de pharmacovigilance et d'addictovigilance répondant aux normes des bonnes pratiques de publication. Elle propose également des comptes rendus et actes de congrès, et des numéros à thème en rapport avec l'actualité. Thérapies est indexé dans les principales bases de données biomédicales: Biosis Previews/Biological Abstracts, Embase/Excerpta Medica, Medline/Index Medicus, Science Citation Index.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Dominique DeplanquePublisher website
Editorial board by country: none in mainland China; most named France 19 (19 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics9.9%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance8.9%
- Pharmaceutical Practices and Patient OutcomesMedicine6.9%
- Health, Medicine and SocietyHealth Professions6.8%
- Opioid Use Disorder TreatmentMedicine5.7%
- Drug-Induced Adverse ReactionsMedicine5.6%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance5.6%
- Healthcare Systems and PracticesHealth Professions4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbasePublisher website
Other: Index Medicus
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2LetPub ·
- Impact factor (publisher)
- 2.1Publisher website ·
- CiteScore 2026-06
- 3.3LetPub ·
- CiteScore (publisher)
- 3.3Publisher website ·
- SJR 2026-06
- 0.56LetPub ·
- SNIP 2026-06
- 0.76LetPub ·
- h-index
- 33LetPub ·
- h-index
- 46OpenAlex ·
- i10-index
- 400OpenAlex ·
- 2-year mean citedness
- 1.17OpenAlex ·
- Self-citation rate
- 9.5%LetPub ·
- Share of gold OA articles
- 23.98%LetPub ·
Volume
- Articles per year
- 62LetPub ·
Articles by year OpenAlex count · 2,751 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 17 | 7 |
| 2025 | 93 | 36 | 63 |
| 2024 | 139 | 60 | 259 |
| 2023 | 99 | 64 | 463 |
| 2022 | 174 | 78 | 695 |
| 2021 | 169 | 60 | 617 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
93 daysMedian, submission to acceptance · P25–P75 50 days – 139 days
- Acceptance to online
- median 9 days (98 articles)
- Submission to online
- median 104 days
- Sample
- 98 articles with submission and acceptance dates (180 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- First decision after review
- 46 daysPublisher website ·
- Submission to acceptance
- 107 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,450 / EUR 3,150 / GBP 2,760 / JPY 427,900 | — | — | |
| Publisher website | USD 3,450 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 3,450 (excluding taxes). The amount you pay may be reduced during submission if applicable.Review this journal’s open access policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Masson SAS
- Country or region
- FRANCE
- Language
- French
- Frequency
- Bimonthly
- Founded
- 1946
- ISSN
- 0040-5957
- Electronic ISSN
- 1958-5578
- Society / sponsor
- Société Française de Pharmacologie et de Thérapeutique
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about THERAPIE
What CAS zone is THERAPIE in?
In the 2025 upgraded edition of the CAS Journal Ranking, THERAPIE is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of THERAPIE?
The latest impact factor listed by LetPub is 2; CiteScore 3.3, h-index 46.
How long does peer review take at THERAPIE?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 93 days (interquartile range 50–139 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of THERAPIE based?
Of the 19 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (19). Counted from the institutions listed on the board page; for reference only.
Which databases index THERAPIE?
According to LetPub and DOAJ records, THERAPIE is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and Embase; that list has not been checked against each database.
Is THERAPIE open access, and what is the APC?
THERAPIE is a hybrid journal. For open-access publication: APC about USD 3,450.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .